MBRX icon

Moleculin Biotech
MBRX

Overview Fund Trends Analyst Outlook Journalist POV

8 hedge funds and large institutions have $326K invested in Moleculin Biotech in 2016 Q2 according to their latest regulatory filings, with 8 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
8
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$132K
2
+$124K
3
+$33K
4
Barclays
Barclays
United Kingdom
+$9K
5
TRCT
Tower Research Capital (TRC)
New York
+$9K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$132K
2
$124K
3
$33K
4
$9K
5
$9K
6
$8K
7
$8K
8
$3K